Beacon Securities analyst Russell Stanley has maintained a “Buy” rating and C$5.00 price target on Curaleaf Holdings ...

The company's international cannabis sales soared by 36%, and it cut its losses in half.

Be careful not to catch a falling knife.

A group of American public legal officials expressed concern about current federal law covering hemp. They feel that although it was legalized in 2018, it's only poorly defined in federal law. The ...

Canopy Growth shares are up following President Donald Trump's recent executive order urging the Department of Justice to reschedule cannabis to Schedule 3.

Today, Dec. 18, 2025, investors are weighing Tilray’s fresh U.S. medical push and sector volatility after federal cannabis rescheduling.

YOLO offers global cannabis sector exposure with an actively managed, low-fee structure and $40M in net assets. Learn more ...

Shares of Aurora Cannabis Inc. ACB rallied 2.12% to $4.33 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.91% to ...

Shares of Village Farms International VFF have skyrocketed 328% year to date, significantly outperforming the industry’s 10% decline. This upside can be largely attributed to favorable comments from ...

The Washington Post reports that President Trump will reschedule marijuana as a Schedule III drug. Marijuana is already legal in Canada, but Aurora Cannabis can't seem to make a profit off of it.

This was the stock's third consecutive day of losses.